Real-World Single-Center Experience with Sofosbuvir-Based Regimens for the Treatment of Chronic Hepatitis C Genotype 1 Patients

BACKGROUND/AIMS: The approval of sofosbuvir (SOF), a direct-acting antiviral, has revolutionized the treatment of chronic hepatitis C virus (HCV). METHODS: We assessed the sustained virological response (SVR) of SOF-based regimens in a real-world single-center setting for the treatment of chronic HC...

Descripción completa

Detalles Bibliográficos
Autores principales: Shin, Hyun Phil, Burman, Blaire, Kozarek, Richard A., Zeigler, Amy, Wang, Chia, Lee, Houghton, Zehr, Troy, Edwards, Alicia M., Siddique, Asma
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Editorial Office of Gut and Liver 2017
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5593334/
https://www.ncbi.nlm.nih.gov/pubmed/28651301
http://dx.doi.org/10.5009/gnl16447

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5593334/
https://www.ncbi.nlm.nih.gov/pubmed/28651301
http://dx.doi.org/10.5009/gnl16447

Ejemplares similares